BOSTON (AP) — The chief executive officer of a Boston-area biotech company who said it had developed a painkiller that would replace opioids has ...
News
- Biotech CEO gets 7 years in prison for defrauding investors
- Nvision Biomedical Technologies Expands Lower Extremities Product Portfolio with FDA-cleared ...
Nvision Biomedical Technologies, a San Antonio-based medical device and implant manufacturer, will highlight its growing product portfolio for lower ...
- Worldwide Clinical Trials boosts exec team with new early-phase lead
Mercer will be focusing on Worldwide's bioanalysis lab in Austin, Texas, and the Clinical Pharmacology Unit clinic in San Antonio. This has a focus on ...
- SwRI screening tech advances coronavirus treatment efforts
SwRI will team with local research partners, including the Texas Biomedical Research Institute, for the next phase of studies to find candidates for drug ...
- Bluebird: 4Q Earnings Snapshot
The biotechnology company posted revenue of $10 million in the period, surpassing Street forecasts. Nine analysts surveyed by Zacks expected $9.6 ...